These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 3436115

  • 1. Vitamin C metabolites and microangiopathy in diabetes mellitus.
    Jennings PE, Chirico S, Jones AF, Lunec J, Barnett AH.
    Diabetes Res; 1987 Nov; 6(3):151-4. PubMed ID: 3436115
    [Abstract] [Full Text] [Related]

  • 2. Tissue ascorbic acid and polyol pathway metabolism in experimental diabetes.
    Lindsay RM, Jamieson NS, Walker SA, McGuigan CC, Smith W, Baird JD.
    Diabetologia; 1998 May; 41(5):516-23. PubMed ID: 9628267
    [Abstract] [Full Text] [Related]

  • 3. Disturbed handling of ascorbic acid in diabetic patients with and without microangiopathy during high dose ascorbate supplementation.
    Sinclair AJ, Girling AJ, Gray L, Le Guen C, Lunec J, Barnett AH.
    Diabetologia; 1991 Mar; 34(3):171-5. PubMed ID: 1884888
    [Abstract] [Full Text] [Related]

  • 4. Plasma homocysteine and microvascular complications in type 1 diabetes.
    Vaccaro O, Perna AF, Mancini FP, Iovine C, Cuomo V, Sacco M, Tufano A, Rivellese AA, Ingrosso D, Riccardi G.
    Nutr Metab Cardiovasc Dis; 2000 Dec; 10(6):297-304. PubMed ID: 11302003
    [Abstract] [Full Text] [Related]

  • 5. Role of plasma ascorbate in diabetic microangiopathy.
    Ali SM, Chakraborty SK.
    Bangladesh Med Res Counc Bull; 1989 Dec; 15(2):47-59. PubMed ID: 2629696
    [Abstract] [Full Text] [Related]

  • 6. [The effect of diabetic compensation on plasma levels of dehydroascorbic acid in insulin-dependent diabetics].
    Kábrt J, Kramlová J, Skrha J.
    Cas Lek Cesk; 1987 Nov 13; 126(46):1430-2. PubMed ID: 3690619
    [No Abstract] [Full Text] [Related]

  • 7. Blood vitamin C concentrations in patients with diabetes mellitus.
    Schorah CJ, Bishop N, Wales JK, Hansbro PM, Habibzadeh N.
    Int J Vitam Nutr Res; 1988 Nov 13; 58(3):312-8. PubMed ID: 3198319
    [Abstract] [Full Text] [Related]

  • 8. [The relationship between concentration of growth hormone in serum and microangiopathy in patients with diabetes mellitus].
    Chen M, Yu W, Hu S.
    Zhonghua Yi Xue Za Zhi; 1997 Oct 13; 77(10):765-7. PubMed ID: 9772523
    [Abstract] [Full Text] [Related]

  • 9. Blood levels of total homocysteine in patients with type 1 diabetes (with no complications, diabetic nephropathy and/or retinopathy) and in their non-diabetic relatives.
    Matteucci E, Rossi L, Mariani S, Fagnani F, Quilici S, Cinapri V, Giampietro O.
    Nutr Metab Cardiovasc Dis; 2002 Aug 13; 12(4):184-9. PubMed ID: 12514938
    [Abstract] [Full Text] [Related]

  • 10. Serum antioxidant activity in diabetes mellitus.
    Jones AF, Winkles JW, Jennings PE, Florkowski CM, Lunec J, Barnett AH.
    Diabetes Res; 1988 Feb 13; 7(2):89-92. PubMed ID: 3396268
    [Abstract] [Full Text] [Related]

  • 11. Rheological changes in diabetic microangiopathy.
    Negrean V, Suciu I, Sâmpelean D, Cozma A.
    Rom J Intern Med; 2004 Feb 13; 42(2):407-13. PubMed ID: 15529630
    [Abstract] [Full Text] [Related]

  • 12. Plasma lipid peroxidation and antioxidiant nutrients in type 2 diabetic patients.
    Peerapatdit T, Patchanans N, Likidlilid A, Poldee S, Sriratanasathavorn C.
    J Med Assoc Thai; 2006 Nov 13; 89 Suppl 5():S147-55. PubMed ID: 17718256
    [Abstract] [Full Text] [Related]

  • 13. Uptake mechanisms for ascorbate and dehydroascorbate in lymphoblasts from diabetic nephropathy and hypertensive patients.
    Ng LL, Ngkeekwong FC, Quinn PA, Davies JE.
    Diabetologia; 1998 Apr 13; 41(4):435-42. PubMed ID: 9562348
    [Abstract] [Full Text] [Related]

  • 14. [Evaluation of various hemorheologic parameters in diabetes mellitus].
    Cella A, Bianchi E, Reali GL, Piana A, Armani U.
    Boll Soc Ital Biol Sper; 1990 Apr 13; 66(4):335-42. PubMed ID: 2390223
    [Abstract] [Full Text] [Related]

  • 15. Increased glutathionylated hemoglobin (HbSSG) in type 2 diabetes subjects with microangiopathy.
    Sampathkumar R, Balasubramanyam M, Sudarslal S, Rema M, Mohan V, Balaram P.
    Clin Biochem; 2005 Oct 13; 38(10):892-9. PubMed ID: 16051210
    [Abstract] [Full Text] [Related]

  • 16. [Modification of hemorheological parameters in microvascular complications of diabetes].
    Bauduceau B, Renaudeau C, Mayaudon H, Hélie C, Ducorps M, Sonnet E, Yvert JP.
    Diabete Metab; 1995 Jun 13; 21(3):188-93. PubMed ID: 7556810
    [Abstract] [Full Text] [Related]

  • 17. [Prostacyclin-like activity modifying plasma factors in diabetic microangiopathy].
    Magyari M, Túri S, Csanálosi-Németh M.
    Fortschr Ophthalmol; 1990 Jun 13; 87(3):269-73. PubMed ID: 2115854
    [Abstract] [Full Text] [Related]

  • 18. Oxidative DNA damage and plasma antioxidant capacity in type 2 diabetic patients with good and poor glycaemic control.
    Lodovici M, Giovannelli L, Pitozzi V, Bigagli E, Bardini G, Rotella CM.
    Mutat Res; 2008 Feb 01; 638(1-2):98-102. PubMed ID: 17964614
    [Abstract] [Full Text] [Related]

  • 19. Relationship of oxidative stress and fibrinolysis in diabetes mellitus.
    Skrha J, Hodinár A, Kvasnicka J, Hilgertová J.
    Diabet Med; 1996 Sep 01; 13(9):800-5. PubMed ID: 8891455
    [Abstract] [Full Text] [Related]

  • 20. Plasma fibronectin in diabetic retinopathy and macroangiopathy.
    Seghieri G, Bartolomei G, De Giorgio LA.
    Diabete Metab; 1986 Aug 01; 12(4):186-90. PubMed ID: 3770274
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.